Bullish on $PFE Pfizer as support level increases.
Pfizer looks to have created some distance from its post earnings volatility, established succeeding higher-highs, backed by corporate news of new Operating Chief, and looks like could sustain a positive trend to close out 2017.
免責聲明
這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。